A fixed-dose combination of meloxicam and rizatriptan (Symbravo) for migraine.Med Lett Drugs Ther. 2025 Apr 28; 67(1727):68-70.ML
Links
Pub Type(s)
Journal Article
Language
eng
PubMed ID
40261316
Citation
"A Fixed-dose Combination of Meloxicam and Rizatriptan (Symbravo) for Migraine." The Medical Letter On Drugs and Therapeutics, vol. 67, no. 1727, 2025, pp. 68-70.
A fixed-dose combination of meloxicam and rizatriptan (Symbravo) for migraine. Med Lett Drugs Ther. 2025;67(1727):68-70.
(2025). A fixed-dose combination of meloxicam and rizatriptan (Symbravo) for migraine. The Medical Letter On Drugs and Therapeutics, 67(1727), 68-70. https://doi.org/10.58347/tml.2025.1727b
A Fixed-dose Combination of Meloxicam and Rizatriptan (Symbravo) for Migraine. Med Lett Drugs Ther. 2025 Apr 28;67(1727):68-70. PubMed PMID: 40261316.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - A fixed-dose combination of meloxicam and rizatriptan (Symbravo) for migraine.
PY - 2025/4/22/medline
PY - 2025/4/22/pubmed
PY - 2025/4/22/entrez
KW - Maxalt
KW - NSAIDs
KW - Nurtec
KW - Reyvow
KW - Symbravo
KW - Treximet
KW - Ubrelvy
KW - adverse effects
KW - dihydroergotamine
KW - dosage
KW - drug interactions
KW - efficacy
KW - lactation
KW - lasmiditan
KW - meloxicam
KW - migraine
KW - naproxen
KW - pregnancy
KW - rimegepant
KW - rizatriptan
KW - safety
KW - sumatriptan
KW - ubrogepant
SP - 68
EP - 70
JF - The Medical letter on drugs and therapeutics
JO - Med Lett Drugs Ther
VL - 67
IS - 1727
SN - 1523-2859
UR - https://www.unboundmedicine.com/medline/citation/40261316/A_fixed-dose_combination_of_meloxicam_and_rizatriptan_
DB - PRIME
DP - Unbound Medicine
ER -
Try the Free App:
